Open | - |
Close | - |
Volume / Avg. | 28.000 / 3.488M |
Day Range | - - - |
52 Wk Range | 0.649 - 6.980 |
Market Cap | $5.775M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 1.21% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Enveric Biosciences (NASDAQ: ENVB) through any online brokerage.
Other companies in Enveric Biosciences’s space includes: Cingulate (NASDAQ:CING), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC) and Jaguar Health (NASDAQ:JAGX).
The latest price target for Enveric Biosciences (NASDAQ: ENVB) was reported by HC Wainwright & Co. on Tuesday, January 30, 2024. The analyst firm set a price target for 10.00 expecting ENVB to rise to within 12 months (a possible 834.58% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Enveric Biosciences (NASDAQ: ENVB) is $1.07 last updated March 18, 2024 at 7:56 PM EDT.
There are no upcoming dividends for Enveric Biosciences.
Enveric Biosciences’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Enveric Biosciences.
Enveric Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.